The present invention provides compositions suitable for use as biomarkers of vulnerable plaques as well as methods for the use of such compositions. In preferred embodiments, specific molecular imaging agents are provided that permit the selective identification of vulnerable plaques in coronary and...http://www.google.com/patents/US7560227?utm_source=gb-gplus-sharePatent US7560227 - Biomarkers of vulnerable atherosclerotic plaques and methods of use
